Estrogen | Undiagnosed abnormal genital bleeding Known, suspected, or history of breast cancer except in appropriately selected patients being treated for metastatic disease Known or suspected estrogen-dependent neoplasia Active deep venous thrombosis, pulmonary embolism, or a history of these conditions Active or recent (within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction) Liver dysfunction or disease Known thrombophilic disorders (e.g., protein C, protein S, antithrombin deficiency) Known hypersensitivity to any of the ingredients in this product Known or suspected pregnancy
|
Conjugated estrogens (Premarin) |
Estropipate |
Estradiol oral tablet (Estrace) |
Estradiol weekly transdermal patch (Climara, Menostar) |
Estradiol biweekly transdermal patch (Alora, Vivelle Dot) |
Estrogen/progestin |
Conjugated estrogens/medroxyprogesterone acetate (continuous-cyclic; Premphase) |
Conjugated estrogens/medroxyprogesterone acetate (continuous-combined; Prempro) |
Ethinyl estradiol/norethindrone acetate (Femhrt) |
Estradiol/norethindrone acetate (Activella) |
Estradiol/norgestimate (intermittent-combined; Prefest) |
Estradiol/levonorgestrel (continuous-combined; Climara Pro) |